Sections
| 70.14.020 | State agencies to identify alternative health care providers. | |
| 70.14.030 | Health care utilization review procedures. | |
| 70.14.040 | Review of prospective rate setting methods. | |
| 70.14.050 | Drug purchasing cost controls—Establishment of evidence-based prescription drug program. | |
| 70.14.060 | Prescription drug purchasing consortium—Participation—Exceptions—Rules. | |
| 70.14.065 | Generic prescription drug partnership agreements. | |
| 70.14.070 | Prescription drug consortium account. | |
| 70.14.080 | Definitions. | |
| 70.14.090 | Health technology clinical committee. | |
| 70.14.100 | Health technology selection and assessment. | |
| 70.14.110 | Health technology clinical committee determinations. | |
| 70.14.120 | Agency compliance with committee determination—Coverage and reimbursement determinations for nonreviewed health technologies—Appeals. | |
| 70.14.130 | Health technology clinical committee—Public notice. | |
| 70.14.140 | Applicability to health care services purchased from health carriers. | |
| 70.14.150 | Data-sharing agreements—Report. | |
| 70.14.155 | Streamlined health care administration—Agency participation. | |
| 70.14.165 | Total cost of insulin work group—Authority implementation. | |
| 70.14.170 | Opioid overdose reversal medications—Bulk purchasing and distribution—Rules—Report—Recommendation to legislature. | |
| 70.14.175 | Opioid overdose reversal medication account. |
Notes:
State health care cost containment policies: RCW 43.41.160.